Protara Therapeutics, Inc. Depreciation
Protara Therapeutics, Inc. (TARA) reported Depreciation of $162.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-11
- Protara Therapeutics, Inc. depreciation for the quarter ending 2026-06-30 was $72.00K, a 26.53% decline year-over-year.
- Protara Therapeutics, Inc. depreciation for the quarter ending 2026-03-31 was $90.00K, a 8.43% increase year-over-year.
- Protara Therapeutics, Inc. depreciation for the quarter ending 2025-12-31 was $93.00K, a 13.41% increase year-over-year.
- Protara Therapeutics, Inc. depreciation for the quarter ending 2025-09-30 was $88.00K, a 4.76% increase year-over-year.
- Protara Therapeutics, Inc. depreciation for fiscal 2025 was $362.00K, a 9.04% increase from fiscal 2024.
- Protara Therapeutics, Inc. depreciation for fiscal 2024 was $332.00K, a 2.64% decline from fiscal 2023.
- Protara Therapeutics, Inc. depreciation for fiscal 2023 was $341.00K, a 37.50% increase from fiscal 2022.
- Protara Therapeutics, Inc. depreciation for fiscal 2022 was $248.00K, a 111.97% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $72.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $162.00K 10-Q · filed 2026-08-11 | $255.00K derived: sum of 3 quarters · filed 2026-08-11 | $343.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | $90.00K 10-Q · filed 2026-05-13 | $183.00K derived: sum of 2 quarters · filed 2026-05-13 | $271.00K derived: sum of 3 quarters · filed 2026-05-13 | $369.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | $93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $181.00K derived: sum of 2 quarters · filed 2026-03-10 | $279.00K derived: sum of 3 quarters · filed 2026-08-11 | $362.00K 10-K · filed 2026-03-10 | ||||
| 2025-09-30 | $88.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $186.00K derived: sum of 2 quarters · filed 2026-08-11 | $269.00K 10-Q · filed 2025-11-10 | $351.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | $98.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $181.00K 10-Q · filed 2026-08-11 | $263.00K derived: sum of 3 quarters · filed 2026-08-11 | $347.00K derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | $83.00K 10-Q · filed 2026-05-13 | $165.00K derived: sum of 2 quarters · filed 2026-05-13 | $249.00K derived: sum of 3 quarters · filed 2026-05-13 | $332.00K derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $82.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $166.00K derived: sum of 2 quarters · filed 2026-03-10 | $249.00K derived: sum of 3 quarters · filed 2026-03-10 | $332.00K 10-K · filed 2026-03-10 | ||||
| 2024-09-30 | $84.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $167.00K derived: sum of 2 quarters · filed 2025-11-10 | $250.00K 10-Q · filed 2025-11-10 | $357.00K derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | $83.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $166.00K 10-Q · filed 2025-08-11 | $273.00K derived: sum of 3 quarters · filed 2025-08-11 | $352.00K derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | $83.00K 10-Q · filed 2025-05-08 | $190.00K derived: sum of 2 quarters · filed 2025-05-08 | $269.00K derived: sum of 3 quarters · filed 2025-05-08 | $347.00K derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | $107.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $186.00K derived: sum of 2 quarters · filed 2025-03-05 | $264.00K derived: sum of 3 quarters · filed 2025-03-05 | $341.00K 10-K · filed 2025-03-05 | ||||
| 2023-09-30 | $79.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $157.00K derived: sum of 2 quarters · filed 2024-11-12 | $234.00K 10-Q · filed 2024-11-12 | $309.00K derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $155.00K 10-Q · filed 2024-08-06 | $230.00K derived: sum of 3 quarters · filed 2024-08-06 | $294.00K derived: sum of 4 quarters · filed 2024-08-06 | ||||
| 2023-03-31 | $77.00K 10-Q · filed 2024-05-02 | $152.00K derived: sum of 2 quarters · filed 2024-05-02 | $216.00K derived: sum of 3 quarters · filed 2024-05-02 | $269.00K derived: sum of 4 quarters · filed 2024-05-02 | ||||
| 2022-12-31 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $139.00K derived: sum of 2 quarters · filed 2024-03-13 | $192.00K derived: sum of 3 quarters · filed 2024-03-13 | $248.00K 10-K · filed 2024-03-13 | ||||
| 2022-09-30 | $64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $117.00K derived: sum of 2 quarters · filed 2023-11-03 | $173.00K 10-Q · filed 2023-11-03 | $227.00K derived: sum of 4 quarters · filed 2023-11-03 | ||||
| 2022-06-30 | $53.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $109.00K 10-Q · filed 2023-08-03 | $163.00K derived: sum of 3 quarters · filed 2023-08-03 | $139.00K derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2022-03-31 | $56.00K 10-Q · filed 2023-05-04 | $110.00K derived: sum of 2 quarters · filed 2023-05-04 | $86.00K derived: sum of 3 quarters · filed 2023-05-04 | $141.00K derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $30.00K derived: sum of 2 quarters · filed 2023-03-08 | $85.00K derived: sum of 3 quarters · filed 2023-03-08 | $117.00K 10-K · filed 2023-03-08 | ||||
| 2021-09-30 | -$24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $31.00K derived: sum of 2 quarters · filed 2022-11-03 | $63.00K 10-Q · filed 2022-11-03 | $95.00K derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | $55.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $87.00K 10-Q · filed 2022-08-09 | $119.00K derived: sum of 3 quarters · filed 2022-08-09 | $146.00K derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | $32.00K 10-Q · filed 2022-05-05 | $64.00K derived: sum of 2 quarters · filed 2022-05-05 | $91.00K derived: sum of 3 quarters · filed 2022-05-05 | $85.00K derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $59.00K derived: sum of 2 quarters · filed 2022-03-09 | $53.00K derived: sum of 3 quarters · filed 2022-03-09 | $103.00K 10-K · filed 2022-03-09 | ||||
| 2020-09-30 | $27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $21.00K derived: sum of 2 quarters · filed 2021-11-04 | $71.00K 10-Q · filed 2021-11-04 | $71.38K 10-Q · filed 2020-11-12 | -$192.00K derived: sum of 4 quarters · filed 2021-11-04 | |||
| 2020-06-30 | -$6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $44.00K 10-Q · filed 2021-08-05 | $44.29K 10-Q · filed 2020-07-31 | -$219.00K derived: sum of 3 quarters · filed 2021-08-05 | -$119.00K derived: sum of 4 quarters · filed 2021-08-05 | |||
| 2020-03-31 | $50.00K 10-Q · filed 2021-05-06 | $49.81K 10-Q · filed 2020-05-13 | -$213.00K derived: sum of 2 quarters · filed 2021-05-06 | -$113.00K derived: sum of 3 quarters · filed 2021-05-06 | -$92.00K derived: sum of 4 quarters · filed 2021-05-06 | |||
| 2019-12-31 | -$263.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$163.00K derived: sum of 2 quarters · filed 2021-03-11 | -$142.00K derived: sum of 3 quarters · filed 2021-03-11 | $16.00K 10-K · filed 2021-03-11 | $279.00K 10-K · filed 2020-03-20 | |||
| 2019-09-30 | $100.00K 10-Q · filed 2019-10-31 | $121.00K derived: sum of 2 quarters · filed 2019-10-31 | $279.00K 10-Q · filed 2019-10-31 | $327.00K derived: sum of 4 quarters · filed 2020-03-20 | ||||
| 2019-06-30 | $21.00K 10-Q · filed 2019-08-07 | $196.00K 10-Q · filed 2019-08-07 | $227.00K derived: sum of 3 quarters · filed 2020-03-20 | $249.00K derived: sum of 4 quarters · filed 2020-03-20 | ||||
| 2019-03-31 | $174.00K 10-Q · filed 2019-05-08 | $206.00K derived: sum of 2 quarters · filed 2020-03-20 | $228.00K derived: sum of 3 quarters · filed 2020-03-20 | $257.00K derived: sum of 4 quarters · filed 2020-03-20 | ||||
| 2018-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-20 | $54.00K derived: sum of 2 quarters · filed 2020-03-20 | $83.00K derived: sum of 3 quarters · filed 2020-03-20 | $115.00K 10-K · filed 2020-03-20 | ||||
| 2018-09-30 | $22.00K 10-Q · filed 2019-10-31 | $51.00K derived: sum of 2 quarters · filed 2019-10-31 | $83.00K 10-Q · filed 2019-10-31 | $116.00K derived: sum of 4 quarters · filed 2019-10-31 | ||||
| 2018-06-30 | $29.00K 10-Q · filed 2019-08-07 | $61.00K 10-Q · filed 2019-08-07 | $94.00K derived: sum of 3 quarters · filed 2019-08-07 | $132.00K derived: sum of 4 quarters · filed 2019-08-07 | ||||
| 2018-03-31 | $32.00K 10-Q · filed 2019-05-08 | $65.00K derived: sum of 2 quarters · filed 2019-05-08 | $103.00K derived: sum of 3 quarters · filed 2019-05-08 | $140.00K derived: sum of 4 quarters · filed 2019-05-08 | ||||
| 2017-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $71.00K derived: sum of 2 quarters · filed 2019-03-13 | $108.00K derived: sum of 3 quarters · filed 2019-03-13 | $148.00K 10-K · filed 2019-03-13 | ||||
| 2017-09-30 | $38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $75.00K derived: sum of 2 quarters · filed 2018-11-07 | $115.00K 10-Q · filed 2018-11-07 | |||||
| 2017-06-30 | $37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $77.00K 10-Q · filed 2018-08-07 | ||||||
| 2017-03-31 | $40.00K 10-Q · filed 2018-05-09 | |||||||
| 2016-12-31 | $123.00K 10-K · filed 2019-03-13 | |||||||
| 2015-12-31 | $57.00K 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |